KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Inventory (2016 - 2025)

Merck (MRK) has disclosed Inventory for 17 consecutive years, with $6.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Inventory rose 8.99% to $6.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $6.7 billion, a 8.99% increase, with the full-year FY2025 number at $6.7 billion, up 8.99% from a year prior.
  • Inventory was $6.7 billion for Q4 2025 at Merck, up from $6.4 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $6.7 billion in Q4 2025 to a low of $5.5 billion in Q2 2021.
  • A 5-year average of $6.1 billion and a median of $6.1 billion in 2023 define the central range for Inventory.
  • Peak YoY movement for Inventory: fell 9.81% in 2022, then grew 11.04% in 2024.
  • Merck's Inventory stood at $6.0 billion in 2021, then dropped by 0.71% to $5.9 billion in 2022, then rose by 7.56% to $6.4 billion in 2023, then dropped by 3.92% to $6.1 billion in 2024, then increased by 8.99% to $6.7 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Inventory are $6.7 billion (Q4 2025), $6.4 billion (Q3 2025), and $6.6 billion (Q2 2025).